Course Objectives
Prescription drug misuse can have serious medical consequences. According to the NIH, Increases in prescription drug misuse over the last 15 years are reflected in increased emergency room visits, overdose deaths associated with prescription drugs, and treatment admissions for prescription drug use disorders, the most severe form of which is addiction. Among those who reported past-year nonmedical use of a prescription drug, nearly 12 percent met criteria for prescription drug use disorder. Unintentional overdose deaths involving opioid pain relievers have more than quadrupled since 1999 and have outnumbered those involving heroin and cocaine since 2002. This 9-part program will cover proper use of opioids and benzodiazepines as well as using and interpreting the PDMP and will examine the FDA’s methodology for human abuse liability.
Instructors
Tresa Binek, PharmD, MBA, Clinical Pharmacist Resident, Pharmacy Inpatient Services, University of WI Hospital and Clinics, Madison, WI
Randall Brown, MD, Associate Professor, University of WI, School of Medicine and Public Health, Madison, WI
Theresa Frey, PharmD, BCPP, Clinical Instructor, University of WI, Madison School of Pharmacy, Madison, WI
Barry Gidal, PharmD, FAES, Professor (CHS), UW-Madison School of Pharmacy, Madison, WI
Joseph Halfpap, PharmD, BCPS, Clinical Instructor, University of WI Hospital and Clinics, Madison, WI
Jennifer Hetzel, PharmD, BCACP, Outpatient Pharmacy Coordinator, University of WI Hospital and Clinics, Madison, WI
Tyler Ho, PharmD, BCACP, Outpatient Pharmacy Coordinator, University of WI Hospital and Clinics, Madison, WI
Paul Hutston, PharmD, BCOP, Professor (CHS), University of Wisconsin School of Pharmacy, Madison, WI
Clare McMahon PharmD, Clinical Pharmacy Resident-Emergency Medicine, University of WI Hospital and Clinics, Madison, WI
Mollie Sloot, PharmD, Pain Clinical Pharmacy Specialist, Tomah VA Medical Center, Tomah, WI
Policy on Faculty and Sponsor Disclosure
It is the policy of the University of Wisconsin – Madison ICEP that the faculty, authors, planners, and other persons who may influence content of this activity disclose all relevant financial relationships with commercial interests in order to allow staff to identify and resolve any potential conflicts of interest. Faculty must also disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation(s). Detailed disclosures will be made in the activity handout materials.
CE Credit
|
 Accreditation Statements
In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
|
Credit Designation Statements
Accreditation Council for Pharmacy Education (ACPE)
The University of Wisconsin-Madison ICEP designates this enduring knowledge-based activity for 12 hours (1.2 CEUs) of CPE credit. Credit can be earned by successfully completing the assessment (70% or better score) and evaluation. Credit will be provided to NABP CPE Monitor within 60 days after the activity completion. There will be no partial credit awarded for partial completion.
Enduring (home study): JA0000358-0000-18-084-H01-P
Release Date: 09/11/2018 Expiration Date: 9/11/2021
American Nurses Credentialing Center (ANCC) & Iowa Board of Nursing
The University of Wisconsin-Madison ICEP designates this enduring study activity for a maximum of 12 ANCC contact hours. (ANCC pharmacotherapeutic contact hours will be calculated and awarded as appropriate to meet the needs of advanced practice nurses.) The University of Wisconsin–Madison School of Nursing is Iowa Board of Nursing provider 350. A copy of the evaluation may be sent to the Iowa Board of Nursing, 400 SW 8th Street, Suite B, Des Moines, IA 50309.
American Medical Association (AMA)
The University of Wisconsin–Madison ICEP designates this enduring activity for a maximum of 12.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Education Units (CEUs)
The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 1.2 CEUs or 12 hours.
Prescription drug misuse can have serious medical consequences. According to the NIH, Increases in prescription drug misuse over the last 15 years are reflected in increased emergency room visits, overdose deaths associated with prescription drugs, and treatment admissions for prescription drug use disorders, the most severe form of which is addiction.